InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-32.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Mack Anthony P., Chairman & CEO. Officer active across 1 company, notably Virpax Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been logged. Breakdown: 2 buys · 0 sell. Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mack Anthony P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
75,750 shares@ €1.279552.3% of flowCommon Stock, $0.00001 par valueSEC:0001493152-22-014659:0
Canonical exit: 16 Aug 2022 (T+90)
25,125 shares@ €3.524447.7% of flowCommon Stock, $0.00001 par valueSEC:0000905718-21-001521:0
Canonical exit: 16 Feb 2022 (T+90)
2 of 2 declarations
About Mack Anthony P.
Mack Anthony P. is the President and CEO of Virpax Pharmaceuticals, Inc. He oversees the company's operations and leads strategic initiatives to develop innovative treatments in the pharmaceutical sector.
